NEW YORK CITY, NY / ACCESS Newswire / July 21, 2025 / WHY: New York, N.Y., July 21, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) between June 22, 2023 and June 24, 2025, both dates inclusive (the "Class Period"), of the important August […]
Featuring Over Double the Cheese and Free Buttery Garlic Dipping Sauce INDIANAPOLIS, IN / ACCESS Newswire / July 21, 2025 / Everyone needs to try Noble Roman’s new ‘Xtra-Stuffed Crust Pizza’! We all love stuffed crust pizza, but Noble Roman’s puts the "Xtra" in its over-the-top, scratch-made version. No string cheese here – with twice
NEW YORK CITY, NY / ACCESS Newswire / July 21, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Petco Health and Wellness Company, Inc. ("Petco" or the "Company") (NASDAQ:WOOF) and certain officers. The class action, filed in the United States District Court for the Southern District of California, and
NEW YORK, NY / ACCESS Newswire / July 21, 2025 / If you suffered a loss on your Fortrea Holdings Inc. (NASDAQ:FTRE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fortrea-holdings-inc-lawsuit-submission-form?prid=157521&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / July 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of KBR, Inc. ("KBR, Inc.") (NYSE:KBR) concerning possible violations of federal securities laws. "HKBR issued a press release on June 20, 2025, announcing that omeSafe Alliance, a KBR . . . Joint Venture,
NEW YORK, NY / ACCESS Newswire / July 21, 2025 / If you suffered a loss on your iRobot Corporation (NASDAQ:IRBT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irobot-corporation-lawsuit-submission-form?prid=157519&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / July 21, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Semler Scientific, Inc. (NASDAQ:SMLR) resulting from allegations that Semler Scientific may have issued materially misleading business information to the investing public. SO WHAT:
NEW YORK, NY / ACCESS Newswire / July 21, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Apple Inc. ("Apple" or the "Company") (NASDAQ:AAPL) and certain officers.�� The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-05197, is on
AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a clinical-stage biotechnology company advancing targeted oligonucleotide therapies for chronic hepatitis B (CHB) functional cure, today announced that the China Center for Drug Evaluation (CDE) has approved the initiation of a Phase III clinical trial for its lead candidate, AHB-137. https://mma.prnewswire.com/media/2143378/AusperBioLogo_Logov1.jpg The Phase III trial
Southern Company today announced a regular quarterly dividend of 74 cents per share on the company's common stock, payable September 8, 2025, to shareholders of record as of August 18, 2025. https://mma.prnewswire.com/media/808925/Southern_Company_Logo.jpg Every quarter for 78 consecutive years, Southern Company has paid a dividend to its shareholders that is equal to or greater than the